Think of a radar scanning for threats before they appear: University of Southampton and Xgenera’s AI test mines microRNA from 10 drops to detect and pinpoint 12 cancers. In NHS trials, this approach could replace invasive biopsies and streamline early treatment.
Key points
- AI-powered blood test detects 12 common cancers with 99% accuracy from just 10 drops
- miONCO-Dx locates tumor origin and reduces need for invasive diagnostics
- NHS clinical trial involves 8,000 patients supported by £2.4 million funding
Q&A
- What is miONCO-Dx?
- How accurate is the test?
- How will it change diagnostics?